| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536516 | Vaccine | 2017 | 8 Pages |
Abstract
We found that vaccinating individuals aged 65-84, 70-84, 75-84, and 80-84 with varicella vaccine to prevent HZ-associated disease in Japan can be cost-effective from societal perspective, with 65-84 y.o. strategy as the optimal alternative. Results are supported by one-way sensitivity analyses and probabilistic sensitivity analyses.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Shu-ling Hoshi, Masahide Kondo, Ichiro Okubo,